1 / 65

Presenter Disclosure Information

Presenter Disclosure Information. In compliance with the accrediting board policies, the American Diabetes Association requires the following disclosure to the participants: NAME OF PRESENTER: Charles Reed, MSN, RN, CNRN Speaker’s Bureau: Indiana University Consultant: Roche Diagnostics.

pillan
Télécharger la présentation

Presenter Disclosure Information

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Presenter Disclosure Information In compliance with the accrediting board policies, the American Diabetes Association requires the following disclosure to the participants: NAME OF PRESENTER: Charles Reed, MSN, RN, CNRN Speaker’s Bureau: Indiana University Consultant: Roche Diagnostics

  2. Inpatient Management Charles Reed MSN, RN, CNRN Patient Care Coordinator Surgical Trauma Intensive Care Unit University Hospital San Antonio, Texas

  3. Objectives • Identify metrics for measuring a glycemic control program • Understand the importance of data in effectively managing a glycemic • Identify barriers related to glycemic control

  4. Background • 24 Million people diagnosed with diabetes • 57 Million with pre-diabetes • $58 Billion in hospital costs • 20-40% Longer LOS CDC Press Release 6/24/2008 ADA Economic Costs of Diabetes in the U.S. in 2007. Diabetes Care, 2008;31(3):596-615

  5. BackgroundDiabetes & Hyperglycemia • Increased complications • Reduction in productivity • EC • PACU • OR • EC Diversion / Canceled elective cases • Increased LOS PACU / ORs on hold • Ill-will between physician & hospital • Increased LOS due to bounce back • Increased healthcare costs

  6. San Antonio Express News 9/9/07 • “University's cramped ER illustrates the problem. It was expanded in the mid-1980s to handle 35,000 patients a year. Today, it sees 70,000 in the same 44 beds.”

  7. What can Healthcare Institutions do to maximize current resources?

  8. Past • Historically little attention paid to glucose control • Lack of benchmarks, guidelines, & evidence1 • Sliding scale insulin protocols • Glucose control started at >200 mg/dl • Minimal insulin used • Insulin drips rare • Fear of hypoglycemia 1ACE/ADA Consensus Statement, Endocrine Practice.2006:12(4)459-468

  9. Present • Van den Berghe (2001) • Reduced Mortality 34%, sepsis 46%, renal failure, blood transfusions, polyneuropathy • Van den Berghe (2006) • Reduced Mortality in those w/ LOS>3 days Van den Berghe et al. Intensive Insulin Therapy in the Critically Ill Patients. N Engl J Med. 2001;345:1359-1367 Van den Berghe et al. Intensive Insulin therapy in the medical ICU. N Engl J Med. 2006;354:449-461

  10. Present • Krinsley (2004) decreased mean blood glucose 152.3-130.7 • 29% reduction in mortality, 75% reduction in new renal insufficiency • Pittas (2004) Meta-analysis 35 clinical trials • Insulin therapy in the ICU decreased short-term mortality by 15% Krinsley J. Effect of Intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004;79(8):992-1000 ACE/ADA Consensus Statement, Endocrine Practice.2006:12(4)459-468

  11. Present • AMI and hyperglycemia • Predictor of mortality • Elevated infarct segments • Cardiac Surgery and hyperglycemia • Independent predictor of infection • Reduction in mortality • Reduction in deep sternal wound infections ACE/ADA Consensus Statement, Endocrine Practice.2006:12(4)459-468

  12. Present • Yendamuri (2003) Hyperglycemia in trauma patients • Higher: LOS, Complications: UTI, Pneumonia, Wound Infection, Bacteremia, and Mortality • Frontera (2006) Hyperglycemia after SAH • Associated with serious complications, increased LOS, and an increased risk of death or disability Yendamuri S. et al. Admission Hyperglycemia as a prognostic indicator in Trauma. J Trauma. 2003;555:33-38 Frontera J et al. Hyperglycemia After SAH Predictors, Associated Complications, and Impact on Outcomes. Stroke. 2006;37:199-203

  13. Benefits of TGC • Patient: • Sepsis • Wound Infection • Dialysis • Blood Transfusions • Polyneuropathy • Ischemic Brain Injury • Respiratory Failure • Pneumonia • Infarct Size of AMI & Stroke

  14. Hyperglycemia • Causes: • Pre-existing Diabetes • Medications • Nutrition • Surgery • Dialysis Solutions • Hypothermia • Anesthesia • Stress Induced Hyperglycemia

  15. Implementing Tight Glycemic Control

  16. STICU Timeline • 2001 - 2002 Research published • 2003 Implementation of TGC • 2004 Multi-disciplinary development of TGC protocol • 2005 Implementation of TGC Protocol, with titration grid • 2006 Implementation of TGCM • 2007 Implementation of TGC in all Adult ICUs

  17. Strategies for Success • Administrative support • Multidisciplinary team • Assessment of current practices • Development of intervention • Order sets • Protocols • Algorithms • Education • Metrics ACE/ADA Consensus Statement, Endocrine Practice.2006:12(4)459-468

  18. Identify Champions: Administration Physician Nursing Laboratory Pharmacy Dietary Case management Information Systems Quality Dept. Implementing TGC Support 1ACE/ADA Consensus Statement, Endocrine Practice.2006:12(4)459-468

  19. Current Practice(Physician) Defining Hyperglycemia Clarify Clinical Triggers Automate the Orders Clarifying Transition Between Drip and S/S

  20. Current Practice(Nurse) Physician Initiating Insulin Drip Physician Order Entry Nurses Titrating Insulin Drips Continuing Insulin Drip Once on Regular Diet

  21. Nurse Doctor • Fear Hypoglycemia • Personal Beliefs • Different Clinical Triggers • Lack of time/ too busy • Don’t know about protocol • Fear Hypoglycemia • Lack of Value TGC • Nurse Avoids Drip • Reluctant to call MD • Does Not Follow Protocol • Dialysis • Bolus Feeds • Feeds Held for procedure • Regular Diet • Delay in receiving drip • Lack of real time value • Reactive Instead of Proactive • MD won’t order protocol • Not all units have a protocol • No Standardized Policy Patient Facility / Equipment Policy / Protocol

  22. Barriers Current Practice • Cost • Reduction in LOS • Reduction in blood • Reduction in dialysis • Reduction in diversions • Reduction in antibiotics • Decrease in wait times Increased patient function

  23. Barriers Current Practice • NPO/Feeds held/Regular Diet • IVF changed • Dialysis • Failure to change Insulin dosing • Medication Error • Infrequent blood glucose monitoring • Orders not clearly written • Hypoglycemia

  24. Barriers Current Practice • Organizational • Culture/Training • Workflow habits • Nursing time • Skepticism about benefits • Fear of hypoglycemia • Lack of knowledge • Lack of integration technology • Lack of ownership ACE/ADA Consensus Statement, Endocrine Practice.2006:12(4)459-468

  25. No algorithm available to follow Difference in RN/MD belief for appropriate accucheck levels RN/MD fear of hypoglycemia Pump programming errors Reluctance to call MD regarding hyperglycemia/Inexperience Nurse avoiding initiation of IV drip Tight glycemic control not valued Knowledge deficit for switching from drip to sliding scale or vice versa Delays in starting protocol MD does not order protocol/drip MD avoids protocol Difficulty obtaining admission orders with protocol Protocol not followed at all Protocols differ per unit and per service Glycemic control driven by different trigger values Too many chiefs/no consensus on how to treat Order wrong/inadequate sliding scale or drip Lack of insulin availability Delayed delivery of drip from pharmacy Initiation of dialysis/Termination of dialysis Lack of real time accucheck report capability Patient preference/Patient refusal Inconsistent accucheck source (finger stick vs. blood draw vs. A-line) Conversion to Bolus feeds or PO diet Nurse deviates from protocol Survey Barriers Current Practice

  26. Barriers by Unit Current Practice

  27. Implementing TGC Interventions • Standardization of tight glycemic control protocols mostly….

  28. Implementing TGC Interventions • Yale • Leuven • Portland • Digami • University of Washington • Rush University • Northwestern University Protocols

  29. Implementing TGC Interventions

  30. Implementing TGC Interventions 1 Accucheck >150 Insulin Drip 2 Accuchecks >120

  31. Implementing TGC Interventions • Develop protocol • Prompt users to initiates drip • Permits titration by ICU nurses • Ensure continuous administration of glucose • Specifies frequency glucose monitoring • Specify treatment plan for hypoglycemia. • Ensure nurses can handle increased burden of frequent glucose checks • Transition to subcutaneous insulin

  32. Implementing TGC Interventions • Matheny (2007) • 3616 diabetic patients • 613 Lacking POC BG two days • Colard 2004 • St. Lukes Hospital Kansas City MO • 12,000 POC BG tests month • 400-500 (up to 12.4%) • 274 4.9% • 102 1.7% • 6 .18% Matheny M et al. Treatment Intensification and Blood Glucose Control Among Hospitalized Patients. J Gen Intern Med. 2007;23(2):184-189 Colard D. Reduction in Patient Identification Errors Using Technology. 2004 Clinical Lab Expo AACC

  33. Invalid POC Blood Glucose Monitoring

  34. Implementing TGC Interventions • Education • Physicians • Nurses • Techs • Cook (2008) • S/S vs IV • Options/works? • Policies/protocols? • Target ranges? Cook B et al. Beliefs About Hospital Diabetes and Perceived Barriers to Glucose Management Among Inpatient Midlevel Providers. The Diabetes Educator. 2008;34(1):75-83

  35. Implementing TGC Metrics • Identify Program Goal • 80-110, 80-140 • What are you comfortable with? • Identify how to measure metrics/compliance • Who: QA department, bedside nurse, director, lab, POC office • How: Chart audits, crystal or lab report, data mining software • When: Per shift, daily, weekly, monthly, or quarterly • Identify what to measure • Mean value (basic) good for trending • % values in range (basic) good for trending • % time in range • % time in range by patient (best)

  36. Implementing TGC Metrics • Goal: • Critically Ill patients • 110mg/dl or as close as possible and generally<140mg/dl • Non-Critically Ill patients • 126mg/dl fasting and all random 180-200 ADA. Standards of Medical Care in Diabetes-2008. Diabetes Care. 2008;31(1):S12-S54

  37. Implementing TGC Metrics • Monitor, assess, and reassess • Daily, Weekly, Monthly • Share the results • E-mail • Bulletin board • Staff meeting

  38. STICU Case Study

  39. Insulin Usage • Bags used • 361 in 2003 • 1063 in 2005 • 2427 last 12 months • Patient on Insulin drips • 76 in 2003 (7%) • 193 in 2005 (14.3%) • 510 in last 12 months (33%)

  40. Evaluation of Mean Blood Glucose • 2003 156.1 • 2004 139.5 • 2005 130.8 • 2006 115.0

  41. Evaluation of Mortality Compared to Published Studies • Krinsley (2004) 29.3% reduction in mortality • Van den Bergh (2001) 34% reduction in mortality • Mortality % in STICU 2001 thru 2004 unchanged.

  42. Evaluation of Mortality • 2005 Mortality was reduced by: 30.2% 28 Lives Saved

  43. Journal of American College of Surgeons

  44. Data Mining

  45. Implementation Data Mining Software • A TGC survey was developed to evaluate the nursing staff’s: • Knowledge of existing protocol. • Perceived percentage of effectiveness in achieving target range. • Perceived barriers to TGC. • Knowledge of available research literature on TGC. • Knowledge of benefits related to TGC. • 60 nurses, 92.3% participated in the survey. • 100% knew of the protocol and target range. • 86% believed they achieved target range 50% to 90% • 59% believed they achieved target range 70-90% of the time.

More Related